RDY 📈 Dr. Reddy’s Laboratories - Overview

Dr. Reddy's Laboratories Limited is a global pharmaceutical company that operates through three main segments: Global Generics, Pharmaceutical Services and Active Ingredients (PSAI), and Others. The company's Global Generics segment is responsible for manufacturing and marketing a wide range of prescription and over-the-counter pharmaceutical products, including generic finished dosages that are equivalent to branded formulations. This segment also includes the company's biologics business.

The PSAI segment is focused on producing active pharmaceutical ingredients and intermediates, which are essential components for finished pharmaceutical products. In addition to manufacturing and marketing these ingredients, this segment also provides contract research services and customizes active pharmaceutical ingredients and steroids to meet specific customer requirements.

The Others segment is dedicated to developing innovative therapies in areas such as oncology and inflammation, as well as researching and developing differentiated formulations. This segment also provides digital healthcare and information technology-enabled business support services, further expanding the company's capabilities.

Dr. Reddy's Laboratories offers a diverse range of products across various therapeutic categories, including gastro-intestinal, cardiovascular, anti-diabetic, dermatology, oncology, respiratory, stomatology, urology, and nephrology. With a strong presence worldwide, the company has been a key player in the pharmaceutical industry since its incorporation in 1984 and is headquartered in Hyderabad, India.

For more information, please visit the company's website at https://www.drreddys.com.